ESHAP Salvage Therapy for Refractory and Relapsed Non-Hodgkin's Lymphoma: A Single Center Experience

BACKGROUND: The ESHAP chemotherapy regimen, that is, the combination of the etoposide, methylprednisolone, high-dose cytarabine and cisplatin, has been shown to be active against relapsing or refractory non-Hodgkin's lymphoma (NHL) in previous therapeutic trials. We attempted to determine wheth...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Park, Sang Hyoung, Kim, Shin, Ko, Ok Bae, Koo, Ja Eun, Lee, Danbi, Jeong, Yong Pil, Huh, Jooryung, Kim, Sung-Bae, Kim, Sang We, Lee, Jae-Lyun, Suh, Cheolwon
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Association of Internal Medicine 2006
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3890718/
https://ncbi.nlm.nih.gov/pubmed/17017664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2006.21.3.159
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados